These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2773932)

  • 41. [Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)].
    Belohradsky BH; Hennig N; Marget W; Fudenberg HH
    Klin Wochenschr; 1976 Dec; 54(23):1109-15. PubMed ID: 1003869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basic molecular defect in ADA-SCID.
    Herbschleb-Voogt E; Scholten JW; Vossen JM; Pearson PL; Meera Khan P
    Adv Exp Med Biol; 1984; 165 Pt A():381-4. PubMed ID: 6720406
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic heterogeneity in partial adenosine deaminase deficiency.
    Hirschhorn R; Martiniuk F; Roegner-Maniscalco V; Ellenbogen A; Perignon JL; Jenkins T
    J Clin Invest; 1983 Jun; 71(6):1887-92. PubMed ID: 6863546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adenosine deaminase activity and immune dysfunction (author's transl)].
    Bremer H; Bauer I; Brock J
    Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
    Adams SP; Wilson M; Harb E; Fairbanks L; Xu-Bayford J; Brown L; Kearney L; Madkaikar M; Bobby Gaspar H
    Clin Immunol; 2015 Dec; 161(2):174-9. PubMed ID: 26255240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotype is an important determinant of phenotype in adenosine deaminase deficiency.
    Hershfield MS
    Curr Opin Immunol; 2003 Oct; 15(5):571-7. PubMed ID: 14499267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.
    Shovlin CL; Simmonds HA; Fairbanks LD; Deacock SJ; Hughes JM; Lechler RI; Webster AD; Sun XM; Webb JC; Soutar AK
    J Immunol; 1994 Sep; 153(5):2331-9. PubMed ID: 8051429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
    Schwartz AL; Polmar SH; Stern RC; Cowan DH
    Br J Haematol; 1978 Jun; 39(2):189-94. PubMed ID: 678472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation of cDNA clones for human adenosine deaminase.
    Valerio D; Duyvesteyn MG; Meera Khan P; Geurts van Kessel A; de Waard A; van der Eb AJ
    Gene; 1983 Nov; 25(2-3):231-40. PubMed ID: 6198240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ; Shannon KM; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cloning of cDNA sequences of human adenosine deaminase.
    Wiginton DA; Adrian GS; Friedman RL; Suttle DP; Hutton JJ
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7481-5. PubMed ID: 6200875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
    Arredondo-Vega FX; Santisteban I; Kelly S; Schlossman CM; Umetsu DT; Hershfield MS
    Am J Hum Genet; 1994 May; 54(5):820-30. PubMed ID: 8178821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

  • 54. Analysis of normal and mutant forms of human adenosine deaminase - a review.
    Daddona PE; Kelley WN
    Mol Cell Biochem; 1980 Feb; 29(2):91-101. PubMed ID: 6988697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity.
    Jiang C; Hong R; Horowitz SD; Kong X; Hirschhorn R
    Hum Mol Genet; 1997 Dec; 6(13):2271-8. PubMed ID: 9361033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
    Polmar SH
    Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospects for gene therapy for immunodeficiency diseases.
    Kantoff PW; Freeman SM; Anderson WF
    Annu Rev Immunol; 1988; 6():581-94. PubMed ID: 3289578
    [No Abstract]   [Full Text] [Related]  

  • 58. Prenatal diagnosis for adenosine deaminase deficiency.
    Ziegler JB; Van der Weyden MB; Lee CH; Daniel A
    J Med Genet; 1981 Apr; 18(2):154-6. PubMed ID: 7241535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythrocyte adenosine deaminase overproduction in hereditary hemolytic anemia.
    Chottiner EG; Ginsburg D; Tartaglia AP; Mitchell BS
    Blood; 1989 Jul; 74(1):448-53. PubMed ID: 2752123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.